©The Author(s) 2024.
World J Virol. Mar 25, 2024; 13(1): 89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Table 1 Patient demographics of the chronic hepatitis group
| Patient demographics | Number of patients | Percentage | |
| Sex | Female | 1 | 11.1 |
| Male | 8 | 88.9 | |
| Malignancy | ALL | 1 | 11.1 |
| Colon | 2 | 22.2 | |
| HCC | 5 | 55.6 | |
| Pancreas | 1 | 11.1 | |
| USG | Coarse liver | 5 | 55.6 |
| Normal | 4 | 44.4 | |
| Past history of jaundice | No | 4 | 44.4 |
| Yes | 5 | 55.6 | |
| Positive family history | No | 8 | 88.9 |
| Yes | 1 | 11.1 | |
| Past history of surgeries | No | 8 | 88.9 |
| Yes | 1 | 11.1 | |
| History of transfusion in the past | No | 8 | 88.9 |
| Yes | 1 | 11.1 | |
| History of acute hepatitis B in the past | No | 6 | 66.6 |
| Yes | 3 | 33.3 | |
- Citation: Sudevan N, Manrai M, Tilak TVSVGK, Khurana H, Premdeep H. Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study. World J Virol 2024; 13(1): 89104
- URL: https://www.wjgnet.com/2220-3249/full/v13/i1/89104.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i1.89104